Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

REXN

Rexahn Pharmaceuticals (REXN)

Rexahn Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:REXN
일자시간출처헤드라인심볼기업
2023/06/1505:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/06/0919:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/06/0907:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/06/0305:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/05/1521:23Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/05/1521:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/05/0205:16Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/05/0205:13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/04/2121:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/04/0606:05Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/03/3106:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/03/3022:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/02/1504:04Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/01/2606:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/01/1308:09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/01/1307:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/01/1307:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/01/1307:29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
2023/01/0623:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
2022/12/0620:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
2022/11/0806:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
2022/10/2105:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
2022/10/1500:33Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
2022/10/0422:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
2022/09/0905:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
2022/08/1306:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:REXNRexahn Pharmaceuticals Inc
2022/08/1220:53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REXNRexahn Pharmaceuticals Inc
2022/07/0707:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
2022/07/0706:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
2022/07/0706:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REXNRexahn Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:REXN